Atrial fibrillation is currently recognized as a medical condition associated with clinically relevant symptoms, worse prognosis, and increased medical costs. Atrial fibrillation does not seem to be a homogenous disease but presents significant variability in terms of epidemiology, clinical presentation, risk factors, access to treatment, and prognosis. Understanding regional, social, and ethnic variations is thus of paramount importance. It is estimated that more than 33 million individuals worldwide are affected with atrial fibrillation, and the prevalence is expected to grow […]